1.56
-0.03 (-1.58%)
| Previous Close | 1.58 |
| Open | 1.58 |
| Volume | 30,137 |
| Avg. Volume (3M) | 40,707 |
| Market Cap | 144,519,536 |
| Price / Book | 7.53 |
| 52 Weeks Range | |
| Earnings Date | 28 Jul 2025 - 1 Aug 2025 |
| Profit Margin | -76.77% |
| Operating Margin (TTM) | -95.93% |
| Diluted EPS (TTM) | -0.070 |
| Quarterly Revenue Growth (YOY) | -47.50% |
| Total Debt/Equity (MRQ) | 18.26% |
| Current Ratio (MRQ) | 8.56 |
| Operating Cash Flow (TTM) | -9.50 M |
| Levered Free Cash Flow (TTM) | -6.08 M |
| Return on Assets (TTM) | -23.79% |
| Return on Equity (TTM) | -58.61% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | EMVISION FPO [EMV] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -4.0 |
| Average | -0.88 |
|
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 35.88% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |